Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

NLSP
NLS Pharmaceutics Ltd.
stock NASDAQ

At Close
Sep 17, 2025 3:59:30 PM EDT
2.01USD-5.189%(-0.11)165,521
2.01Bid   2.03Ask   0.02Spread
Pre-market
Sep 16, 2025 9:17:30 AM EDT
2.14USD+0.943%(+0.02)0
After-hours
Sep 16, 2025 4:26:30 PM EDT
2.06USD-2.138%(-0.05)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
8.59M
Industry
Biotechnology
Last Split
Sep 27, 20241for40reverse
NLSP Stats
Avg. Vol. 10 Day
242,726
Avg. Vol. 30 Day
199,250
Market Cap
8,589,090
Shares Out.
4,252,025
On/Off Exchange
38%/62%
6 Month Beta
0.44
1 Year Beta
0.30
2 Year Beta
0.33
3 Year Beta
0.39
52 Week Low
1.30
52 Week High
6.97
SMA50
2.18
SMA200
2.02
1 Week
-2.42%
1 Month
-21.71%
3 Month
-11.79%
6 Month
+30.32%
1 Year
-64.51%
2 Year
-93.84%
5 Year
-98.25%
Profile
mission & values to serve our patients we design affordable, safe and effective therapeutics to safeguard and empower the brain throughout all stages of life. we value partnership and integrity, we are ethical and responsible and show respect and compassion for our patients. r&d strategy the successful companies of tomorrow are those that go beyond delivering products to delivering real solutions and services. r&d is the cornerstone of our company and we promote ingenuity through an effective intellectual property policy. the advancements in science mean that more targeted, more (cost-)effective treatments are within reach and we are here to take on this challenge. our innovative r&d is centered on patients' needs and delivering affordable, safe and effective solutions. not only will these enable us to improve access to quality healthcare and meet unmet needs, but they will also deliver the sustainable growth required to allow us to continue to invest in innovative research & developm

NLSP Stock Summary

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) stock price today is $2.01, and today's volume is 165,521. NLSP is down -5.189% today. The 30 day average volume is 199,250. NLSP market cap is 8.59M with 4,252,025 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC